Histochemical features of stress-induced aggregates in α-synuclein overexpressing cells

Brain Research

Volumn 1004, Issue 1-2, 2004, Pages 83-90

  Matsuzaki, Michiko ^a   Hasegawa, Takafumi ^a   Takeda, Atsushi ^a   Kikuchi, Akio ^a   Furukawa, Katsutoshi ^b   Kato, Yoji ^c   Itoyama, Yasuto ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF HYOGO   (Japan)

Author keywords

Synuclein; Degenerative disease: Parkinson's; Disorders of the nervous system; Histochemical feature; Overexpressing cell

Indexed keywords

3 NITROTYROSINE; ALPHA SYNUCLEIN; GAMMA TUBULIN; REACTIVE OXYGEN METABOLITE; THIOFLAVINE; TYROSINE DERIVATIVE; UBIQUITIN;

ARTICLE; CELL INCLUSION; CYTOPLASM; DOPAMINERGIC NERVE CELL; HISTOCHEMISTRY; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; MICROTUBULE; NEUROPROTECTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; STRESS;

ALPHA-SYNUCLEIN; CELL AGGREGATION; CELL LINE, TUMOR; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION; HUMANS; IRON COMPOUNDS; MUTATION; NERVE TISSUE PROTEINS; REACTIVE OXYGEN SPECIES; SYNUCLEINS;

EID: 1642293184     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.01.017     Document Type: Article

References (29)

1. Baba M., Nakajo S., Tu P.H., Tomita T., Nakaya K., Lee V.M., Trojanowski J.Q., Iwatsubo T. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152:1998;879-884.
2. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3:2000;1301-1306.
3. Feany M.B., Bender W.W. A Drosophila model of Parkinson's disease. Nature. 404:2000;394-398.
4. Giasson B.I., Duda J.E., Murray I.V., Chen Q., Souza J.M., Hurtig H.I., Ischiropoulos H., Trojanowski J.Q., Lee V.M. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science. 290:2000;985-989.
5. Hasegawa T., Yamaguchi K., Wada T., Takeda A., Itoyama Y., Miyagi T. Molecular cloning of mouse ganglioside sialidase and its increased expression in Neuro2a cell differentiation. J. Biol. Chem. 275:2000;8007-8015.
6. Hashimoto M., Hsu L.J., Sisk A., Xia Y., Takeda A., Sundsmo M., Masliah E. Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease. Brain Res. 799:1998;301-306.
7. Kato Y., Wu X., Naito M., Nomura H., Kitamoto N., Osawa T. Immunochemical detection of protein dityrosine in atherosclerotic lesion of apo-E-deficient mice using a novel monoclonal antibody. Biochem. Biophys. Res. Commun. 275:2000;11-15.
8. Kopito R.R. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 10:2000;524-530.
9. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J.T., Schols L., Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18:1998;106-108.
10. Kuzuhara S., Mori H., Izumiyama N., Yoshimura M., Ihara Y. Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study. Acta Neuropathol. (Berl.). 75:1988;345-353.
11. Langston J.W., Ballard P., Tetrud J.W., Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 219:1983;979-980.
12. Lee H.J., Lee S.J. Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells. J. Biol. Chem. 277:2002;48976-48983.
13. Le Goffe C., Vallette G., Jarry A., Bou-Hanna C., Laboisse C.L. The in vitro manipulation of carbohydrate metabolism: a new strategy for deciphering the cellular defence mechanisms against nitric oxide attack. Biochem. J. 344(Pt. 3):1999;643-648.
14. Manning-Bog A.B., McCormack A.L., Purisai M.G., Bolin L.M., Di Monte D.A. Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration. J. Neurosci. 23:2003;3095-3099.
15. McNaught K.S., Shashidharan P., Perl D.P., Jenner P., Olanow C.W. Aggresome-related biogenesis of Lewy bodies. Eur. J. Neurosci. 16:2002;2136-2148.
16. Menegon A., Board P.G., Blackburn A.C., Mellick G.D., Le Couteur D.G. Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet. 352:1998;1344-1346.
17. Munoz E., Oliva R., Obach V., Marti M.J., Pastor P., Ballesta F., Tolosa E. Identification of Spanish familial Parkinson's disease and screening for the Ala53Thr mutation of the alpha-synuclein gene in early onset patients. Neurosci. Lett. 235:1997;57-60.
18. Narhi L., Wood S.J., Steavenson S., Jiang Y., Wu G.M., Anafi D., Kaufman S.A., Martin F., Sitney K., Denis P., Louis J.C., Wypych J., Biere A.L., Citron M. Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation. J. Biol. Chem. 274:1999;9843-9846.
19. Nunomura A., Chiba S., Kosaka K., Takeda A., Castellani R.J., Smith M.A., Perry G. Neuronal RNA oxidation is a prominent feature of dementia with Lewy bodies. NeuroReport. 13:2002;2035-2039.
20. Paxinou E., Chen Q., Weisse M., Giasson B.I., Norris E.H., Rueter S.M., Trojanowski J.Q., Lee V.M., Ischiropoulos H. Induction of alpha-synuclein aggregation by intracellular nitrative insult. J. Neurosci. 21:2001;8053-8061.
21. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
22. Sofic E., Paulus W., Jellinger K., Riederer P., Youdim M.B. Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J. Neurochem. 56:1991;978-982.
23. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature. 388:1997;839-840.
24. Trojanowski J.Q., Lee V.M. Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson's disease and Lewy body dementia. Arch. Neurol. 55:1998;151-152.
25. Uversky V.N., Li J., Fink A.L. Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. J. Biol. Chem. 276:2001;44284-44296.
26. Volles M.J., Lansbury P.T. Jr. Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. Biochemistry. 41:2002;4595-4602.
27. Wolozin B., Golts N. Iron and Parkinson's disease. Neuroscientist. 8:2002;22-32.
28. Zareparsi S., Kaye J., Camicioli R., Kramer P., Nutt J., Bird T., Litt M., Payami H., Kay J. Analysis of the alpha-synuclein G209A mutation in familial Parkinson's disease. Lancet. 351:1998;37-38.
29. Zhang J., Perry G., Smith M.A., Robertson D., Olson S.J., Graham D.G., Montine T.J. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am. J. Pathol. 154:1999;1423-1429.